BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 33879700)

  • 1. Identification of TNIK as a novel potential drug target in thyroid cancer based on protein druggability prediction.
    Yang YF; Yu B; Zhang XX; Zhu YH
    Medicine (Baltimore); 2021 Apr; 100(16):e25541. PubMed ID: 33879700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis.
    Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J
    J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Potential Biomarkers for Thyroid Cancer Using Bioinformatics Strategy: A Study Based on GEO Datasets.
    Shen Y; Dong S; Liu J; Zhang L; Zhang J; Zhou H; Dong W
    Biomed Res Int; 2020; 2020():9710421. PubMed ID: 32337286
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of candidate aberrantly methylated and differentially expressed genes in thyroid cancer.
    Tu Y; Fan G; Xi H; Zeng T; Sun H; Cai X; Kong W
    J Cell Biochem; 2018 Nov; 119(11):8797-8806. PubMed ID: 30069928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Screening and Identification of Key Biomarkers in Inflammatory Breast Cancer Through Integrated Bioinformatic Analyses.
    Wu J; Lv Q; Huang H; Zhu M; Meng D
    Genet Test Mol Biomarkers; 2020 Aug; 24(8):484-491. PubMed ID: 32598242
    [No Abstract]   [Full Text] [Related]  

  • 6. Identification of hub genes in thyroid carcinoma to predict prognosis by integrated bioinformatics analysis.
    Pan Y; Wu L; He S; Wu J; Wang T; Zang H
    Bioengineered; 2021 Dec; 12(1):2928-2940. PubMed ID: 34167437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrated analysis of DNA methylation and transcriptome profiling of polycystic ovary syndrome.
    Liu L; He D; Wang Y; Sheng M
    Mol Med Rep; 2020 May; 21(5):2138-2150. PubMed ID: 32323770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of candidate aberrantly methylated and differentially expressed genes in Esophageal squamous cell carcinoma.
    Han BA; Yang XP; Hosseini DK; Zhang P; Zhang Y; Yu JT; Chen S; Zhang F; Zhou T; Sun HY
    Sci Rep; 2020 Jun; 10(1):9735. PubMed ID: 32546690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MiR-375: A prospective regulator in medullary thyroid cancer based on microarray data and bioinformatics analyses.
    Shi L; Zhao SM; Luo Y; Zhang AW; Wei LH; Xie ZY; Li YY; Ma W
    Pathol Res Pract; 2017 Nov; 213(11):1344-1354. PubMed ID: 29033189
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of key candidate genes and pathways in anaplastic thyroid cancer by bioinformatics analysis.
    Ding YG; Ren YL; Xu YS; Wei CS; Zhang YB; Zhang SK; Guo CA
    Am J Otolaryngol; 2020; 41(3):102434. PubMed ID: 32093976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
    Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
    Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
    Yang C; Gong A
    Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
    [No Abstract]   [Full Text] [Related]  

  • 13. Integrated bioinformatics analysis for the screening of hub genes and therapeutic drugs in ovarian cancer.
    Yang D; He Y; Wu B; Deng Y; Wang N; Li M; Liu Y
    J Ovarian Res; 2020 Jan; 13(1):10. PubMed ID: 31987036
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioinformatics analysis of multi-omics data identifying molecular biomarker candidates and epigenetically regulatory targets associated with retinoblastoma.
    Zeng Y; He T; Liu J; Li Z; Xie F; Chen C; Xing Y
    Medicine (Baltimore); 2020 Nov; 99(47):e23314. PubMed ID: 33217867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Key Pathways and Genes in Anaplastic Thyroid Carcinoma via Integrated Bioinformatics Analysis.
    Hu S; Liao Y; Chen L
    Med Sci Monit; 2018 Sep; 24():6438-6448. PubMed ID: 30213925
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comprehensive bioinformation analysis of methylated and differentially expressed genes in esophageal squamous cell carcinoma.
    Peng H; Wang S; Pang L; Yang L; Chen Y; Cui XB
    Mol Omics; 2019 Feb; 15(1):88-100. PubMed ID: 30706927
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Derivation and Validation of the Potential Core Genes in Pancreatic Cancer for Tumor-Stroma Crosstalk.
    Xue R; Hua L; Xu W; Gao Y; Pang Y; Hao J
    Biomed Res Int; 2018; 2018():4283673. PubMed ID: 30519576
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of key genes of papillary thyroid cancer using integrated bioinformatics analysis.
    Liang W; Sun F
    J Endocrinol Invest; 2018 Oct; 41(10):1237-1245. PubMed ID: 29520684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of Hub Genes in Anaplastic Thyroid Carcinoma: Evidence From Bioinformatics Analysis.
    Li L; Zhu M; Huang H; Wu J; Meng D
    Technol Cancer Res Treat; 2020; 19():1533033820962135. PubMed ID: 33025856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of aberrantly methylated differentially expressed genes in breast cancer by integrated bioinformatics analysis.
    Yi L; Luo P; Zhang J
    J Cell Biochem; 2019 Sep; 120(9):16229-16243. PubMed ID: 31081184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.